[Form 4] ACCO BRANDS Corp Insider Trading Activity

Rhea-AI Filing Summary

ACCO BRANDS Corp director Kathleen S. Dvorak was granted 4,892.2 Restricted Stock Units (RSUs) on 09/10/2025 under the issuer's incentive plan. The RSUs are convertible into one share each of the issuer's common stock and have a $0 stated price. RSUs either vest immediately or on the one-year anniversary of the grant and, in all cases, have been deferred under the company's Deferred Compensation Plan for Non-Employee Directors, payable upon death, disability, or cessation of board service. The Form 4 was signed on 09/11/2025.

Insights

Corporate Governance Expert

TL;DR Routine director compensation grant aligns board incentives with shareholders without immediate cash payout.

The reported transaction reflects a standard non-employee director equity grant in the form of RSUs, deferred under the issuer's deferred compensation plan. Such grants are common for board remuneration and aim to align director and shareholder interests. The grant size (4,892.2 RSUs) converts to the same number of common shares upon payout and carries no exercise price, indicating a straightforward equity-based award rather than an option. There is no disclosure of vesting exceptions beyond immediate or one-year vesting and no indication of accelerated payout conditions beyond death, disability, or cessation of service.

Compensation Analyst

TL;DR Compensation action is routine and administratively deferred; limited near-term financial impact on ACCO.

The grant is structured as RSUs that are either immediately vested or vest after one year, but all are deferred for non-employee directors under the Deferred Compensation Plan, suggesting the company delays share delivery and potential tax events. Because the RSUs have a $0 price and convert one-for-one to common shares, the primary implications are shareholder dilution upon settlement and standard alignment of incentives. The filing does not disclose the grant's value relative to total outstanding shares or whether settlement will be in cash or stock, limiting assessment of materiality.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DVORAK KATHLEEN S

(Last) (First) (Middle)

C/O ACCO BRANDS CORPORATION

(Street)

LAKE ZURICH IL 60047

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACCO BRANDS Corp [ ACCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	09/10/2025		A		4,892.2		(1)	(1)	Common Stock	4,892.2	$0	263,851.23	D

Explanation of Responses:

1. Restricted Stock Units (RSUs) granted under the Issuer's Incentive Plan. RSUs are immediately vested or vest on the one year anniversary of the grant date, but in either case, have been deferred under the Issuer's Deferred Compensation Plan for Non-Employee Directors. Each RSU represents the right to receive one share of the Issuer's common stock upon the earlier of the date of the reporting person's death or disability, or cessation of service as a member of the Board of Directors.

	/s/ Kathryn D. Ingraham, attorney-in-fact for Kathleen S. Dvorak	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Kathleen S. Dvorak report on Form 4 for ACCO (ACCO)?

The Form 4 reports a grant of 4,892.2 Restricted Stock Units (RSUs) on 09/10/2025 under ACCO's incentive plan.

When do the RSUs awarded to the director vest and when are they payable?

RSUs vest either immediately or on the one-year anniversary of the grant date and have been deferred under the company's Deferred Compensation Plan, payable upon death, disability, or cessation of board service.

How many shares will the RSUs convert into for ACCO common stock?

Each RSU represents the right to receive one share of ACCO common stock, so the grant corresponds to 4,892.2 shares upon settlement.

Was there any cash price associated with the RSU grant reported on the Form 4?

No; the RSUs are reported with a $0 stated price and convert one-for-one into common shares.

Who signed the Form 4 filing for this transaction?

The Form 4 was signed by Kathryn D. Ingraham, attorney-in-fact for Kathleen S. Dvorak on 09/11/2025.